Trabeculectomy is not the best surgical option for glaucoma.

The goal of glaucoma surgery should be the preservation of visual function, the avoidance of sight-threatening complications, and the preservation of the quality of life of the patient Curiously, the majority of glaucoma surgeons still consider trabeculectomy the best surgical option for their patients, despite evidence that trabeculectomy cannot meet these goals. The trabeculectomy operation has already been abandoned in favour of the augmented trabeculectomy with the antimetabolite mitomycin-C (MMC) by the majority of UK and US glaucoma specialists. MMC trabeculectomy, however, is not safe. The risk of bleb-related endophthalmitis (BRE) ranges from 15% per patient year to 10% in one year, with 11 recent studies giving an average incidence of 2.8% per year As the mean follow-up of these 11 studies was 19 months, the true incidence may be higher, as institutional reviews of BRE show that the mean time of presentation of BRE is 32 months postoperatively,

作 者：

Wishart,PK

刊 名：

Eye 

年，卷(期)：

2008vol.22(no.5) 

分类号：

 

关键词：

Trabeculectomy  Glaucoma syndrome  小梁切开术

正文语种：

eng 

基金项目：